ResearchReal-world experience of teduglutide for the treatment of short bowel syndrome-associated intestinal failure
Jun 6, 2026Journal ArticleGlucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events in Adults With Obesity and Autoimmune Disease: A Target Trial Emulation.Written by 1 Roon author & 9 others Via The American Heart Association Journals
Jun 6, 2026Journal ArticleGlucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events in Adults With Obesity and Autoimmune Disease: A Target Trial Emulation.Written by 1 Roon author & 9 others Via The American Heart Association Journals
ResearchHealthcare Utilization and Geographic Distribution of Advanced Therapy in Minority Race and Ethnic Groups With Inflammatory Bowel Disease
ResearchEffect of Injectable Dual and Single Agonist Glucagon-Like Peptide-1 Based Therapy on Inflammatory Bowel Disease Activity Among Patients with Obesity
ResearchRecurrence of Drug-Induced Lupus Secondary to Vedolizumab Use in a Patient With Crohn's Disease
ResearchDischarged on Enteral Nutrition: What Now? The Poor State of Outpatient Support for Patients on Enteral Nutrition Support
ResearchHealthcare Utilization Patterns and Excessive Steroid Use in Late Adolescence Age and Young Adults With Crohn's Disease and Ulcerative Colitis
ResearchConcurrent zinc and vitamin B deficiencies in acutely exacerbated inflammatory bowel disease: Case reports
ResearchFailure to thrive: A severe manifestation of interleukin 10 receptor A mutation in adult inflammatory bowel disease